HLX1 Activators are a diverse group of compounds and biological agents that indirectly enhance the functional activity of HLX1, a transcription factor pivotal in hematopoietic cell development and immune response regulation. Compounds like PMA and Bryostatin 1, both PKC agonists, play a significant role in upregulating HLX1 through activation of the PKC pathway. This pathway is crucial for the transcriptional regulation activities of HLX1. Similarly, Forskolin and PGE2, through the elevation of cAMP levels and subsequent activation of PKA, contribute to the enhancement of HLX1 activity. The increase in cAMP levels leads to a cascade of events culminating in the upregulation of HLX1, underlining its role in immune and hematopoietic processes. Dibutyryl-cAMP, mimicking cAMP, further amplifies this pathway, emphasizing the importance of cAMP/PKA signaling in regulating HLX1 activity.
Additionally, biological molecules like Epidermal Growth Factor (EGF), Interleukin-3, and Retinoic Acid, all trans significantly impact HLX1 activity. EGF, through the EGFR pathway, and Interleukin-3, via the JAK/STAT pathway, both lead to the upregulation of HLX1. These pathways are integral to cell differentiation and proliferation, highlighting HLX1's role in these processes. Retinoic Acid, all trans, known for its influence on gene expression, also plays a part in modulating HLX1 activity, essential for immune cell development. Furthermore, Lipopolysaccharide (LPS) and Tumor Necrosis Factor-alpha (TNF-α) activate HLX1 through the TLR4 and TNF-α receptor pathways, respectively, leading to NF-κB pathway activation. This activation underscores the involvement of HLX1 in the immune response and inflammation. IL-1β, through the IL-1 receptor, and FLT3 Ligand, via the FLT3 receptor, further reinforce the significance of HLX1 in hematopoietic stem cell development and immune regulation. Collectively, these HLX1 Activators, through their targeted effects on various signaling pathways, accentuate the critical role of HLX1 in the regulation of immune responses, hematopoietic cell development, and transcriptional regulation, highlighting its significance in these fundamental biological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, a potent activator of protein kinase C (PKC), indirectly enhances HLX1 activity by activating the PKC pathway. PKC activation can lead to downstream signaling events that upregulate HLX1, which is involved in transcriptional regulation and hematopoietic cell development. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1, a PKC agonist, indirectly enhances HLX1 activity. It activates PKC, leading to signaling cascades that can upregulate HLX1, a transcription factor important in immune system development. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an activator of adenylate cyclase, indirectly enhances HLX1 activity by increasing cAMP levels. Elevated cAMP can activate PKA, which in turn can influence pathways that upregulate HLX1 activity. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 indirectly enhances HLX1 activity by activating the EP2/EP4 receptors and subsequent cAMP/PKA signaling. This pathway can lead to the upregulation of HLX1, which plays a role in regulating gene expression related to inflammation and hematopoiesis. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, enhances HLX1 activity by mimicking the action of cAMP. This compound can activate PKA and modulate pathways that lead to the upregulation of HLX1, involved in immune and hematopoietic cell development. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, all trans can enhance HLX1 activity indirectly by influencing gene expression patterns. It can upregulate HLX1, which is important in the development of immune cells and in transcriptional regulation. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS indirectly enhances HLX1 activity by triggering the TLR4 signaling pathway. This activation leads to NF-κB and MAPK pathway activation, which can upregulate HLX1, a factor in immune response and hematopoiesis. | ||||||